UnitedHealth Group is advancing broad health equity initiatives across the nation.
The dedicated team of 325,000 people at UnitedHealth Group remain focused on the health, safety and support of the people and communities we serve.
As part of our commitment to help all people in every community -- driven by values of integrity, compassion, innovation, relationships and performance -- UnitedHealth Group is boldly advancing broad health equity initiatives across the nation. Our efforts are even more important as we see people of color disproportionally impacted by the coronavirus pandemic.
UnitedHealth Group’s health equity initiatives are guided by the organizations robust data. We are leveraging this information and our advanced analytics capacities to promote new scientific discovery, which can help eliminate health disparities.
We established an innovative, community-based care model to provide COVID-19 testing, education and other necessary services to some of the highest-risk and most underserved communities in the country. By focusing on locations hardest hit by COVID-19, along with local community challenges including poverty, crowding, food insecurity, homelessness and other existing social determinants of health, we are providing the highest quality of care to the communities that need it most.
We are researching new COVID-19 treatment approaches in partnership with prominent academic institutions. For example, we are collaborating with the Morehouse School of Medicine to study the effect of sickle cell trait on COVID-19, a trait that is prevalent in 8% to 10% of Black Americans. The results of this cutting-edge research will help one of the groups hardest hit by the coronavirus.
We conducted an ACE inhibitor virtual clinical trial with Yale University by applying artificial intelligence to our data. Our study found that seniors on ACE inhibitors who test positive for COVID-19 are 40% less likely to need hospitalization than those who are not. Understanding there is significant racial disparity in the use of ACE inhibitors to manage hypertension, we are working to rapidly scale this large 10,000-person virtual clinical trial, believed to be the first of its type.
As highlighted on UnitedHealth Group’s Q2 Earnings Conference Call. For detailed financial information featured on UnitedHealth Group’s Q2 Earnings Conference Call, see our news release.
United in the Fight Against COVID-19
We are leveraging our clinical knowledge and expertise to support those we serve and make a meaningful difference in the fight against COVID-19.